Sei Investments CO Adaptive Biotechnologies Corp Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sei Investments CO holds 64,817 shares of ADPT stock, worth $219,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,817

Previous 64,780 0.06%

Holding current value

$219,729

Previous $317,000 34.38%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$2.88 - $4.8 $106 - $177	37 Added 0.06%	64,817 $208,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $761 - $1,172	220 Added 0.34%	64,780 $317,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $102,170 - $170,082	20,152 Added 45.38%	64,560 $351,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $15,184 - $21,537	-2,453 Reduced 5.23%	44,408 $297,000
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $199,609 - $258,725	25,591 Added 120.31%	46,861 $413,000

Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $13,008 - $19,408	2,078 Added 10.83%	21,270 $162,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $14,449 - $28,165	-2,223 Reduced 10.38%	19,192 $137,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $308,691 - $710,472	-48,233 Reduced 69.25%	21,415 $173,000
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $6,486 - $18,524	641 Added 0.93%	69,648 $967,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $110,647 - $161,992	4,396 Added 6.8%	69,007 $1.94 Million
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $56,257 - $74,716	-1,874 Reduced 2.82%	64,611 $2.2 Million
Q2 2021 Aug 06, 2021	SELL	$32.22 - $44.59 $586,081 - $811,092	-18,190 Reduced 21.48%	66,485 $2.72 Million
Q1 2021 May 12, 2021	SELL	$37.26 - $67.74 $1.87 Million - $3.41 Million	-50,272 Reduced 37.25%	84,675 $3.8 Million
Q4 2020 Feb 08, 2021	BUY	$45.01 - $65.47 $684,872 - $996,191	15,216 Added 12.71%	134,947 $7.96 Million
Q3 2020 Dec 04, 2020	SELL	$35.79 - $48.81 $466,272 - $635,896	-13,028 Reduced 9.81%	119,731 $5.83 Million
Q3 2020 Nov 06, 2020	BUY	$35.79 - $48.81 $678,900 - $925,876	18,969 Added 16.67%	132,759 $6.47 Million
Q2 2020 Aug 17, 2020	BUY	$24.95 - $48.38 $1.43 Million - $2.77 Million	57,305 Added 101.45%	113,790 $5.51 Million
Q2 2020 Aug 11, 2020	SELL	$24.95 - $48.38 $1.56 Million - $3.02 Million	-62,477 Reduced 52.52%	56,485 $1.7 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $1.07 Million - $2.15 Million	62,815 Added 111.88%	118,962 $3.31 Million
Q4 2019 Feb 06, 2020	BUY	$24.56 - $32.8 $679,010 - $906,821	27,647 Added 97.01%	56,147 $1.68 Million
Q3 2019 Nov 12, 2019	BUY	$30.31 - $53.51 $399,758 - $705,743	13,189 Added 86.14%	28,500 $881,000
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $617,033 - $739,521	15,311 New	15,311 $740,000

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

2.6K

Put Options Held

143K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $484M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Adaptive Biotechnologies Corp Transaction History